ZEB1 and central nervous system cancer: ZEB2 has previously been confirmed to be associated with the malignant phenotype of glioma [72], and the expression level of ZEB1 was significantly increased in glioma tissues compared to normal brain tissues, being positively correlated with WHO glioma classification [73].